Anna Nowak, MD, PhD, speaks about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19’s effects on mesothelioma in treatment in Australia.
Dr. Nowak is a medical oncologist at Sir Charles Gairdner Hospital (SCGH) and professor within the School of Medicine at The University of Western Australia. She is also a former member of the Foundation’s Science Advisory Board.
Watch MesoTV
This MesoTV interview was made possible by the support of sponsors who have stepped up during this difficult time to ensure that we can continue serving the mesothelioma community. Please take note of them at the beginning of the video: Novocure; Belluck & Fox, LLP; University of Pittsburgh Medical Center (UPMC); Vogelzang Law; and Merrill Lynch.
Get notified when our next video is published by clicking the red “Subscribe” button below.
MesoTV is the Mesothelioma Applied Research Foundation’s recorded video series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.
